AI Article Synopsis

  • The Pakistani pharmaceutical industry is experiencing significant changes, with national firms gaining a larger market share (74.51%) compared to multinational corporations (25.49%).
  • MNCs are facing challenges, including tough competition from local companies and ongoing mergers and acquisitions, which impact their ability to expand operations in the country.
  • The recent deregulation of prices for non-essential medicines by the federal government may encourage MNCs to invest in new technologies and infrastructure, essential for maintaining their market presence and improving operational efficiency.

Article Abstract

The Pakistani pharmaceutical industry cannot ignore the contribution of pharmaceutical multinational corporations (MNCs) in terms of innovation and access to advanced treatments. The sale of a pharmaceutical manufacturing plant by an MNC to a Pakistani company has again sparked a debate on why MNCs are closing manufacturing operations in the country. National firms are currently giving MNCs a tough time in Pakistan. Besides competition, MNCs face mergers and acquisitions that hinder the expansion of existing facilities. In the recent past, there has been a noticeable shift in the market shares of multinational corporations (MNCs) and local companies. The market share of national firms has gradually increased, reaching 74.51%, while the market share of MNCs has decreased, falling to 25.49%. These local companies have increasingly partnered with foreign companies through joint ventures, which has had a positive impact on their growth and market share. Nevertheless, the federal government recently deregulated prices for non-essential medicines, so it is expected that MNCs will show their commitment to Pakistan by investing in the country. Investing in new molecules and infrastructure is necessary for MNCs in order to maintain their position in the market. Infrastructure investment is crucial for the smooth operation of pharmaceutical firms. This includes the construction of state-of-the-art manufacturing facilities, the establishment of research and development centres, and the upgrading of technology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578402PMC
http://dx.doi.org/10.1080/20523211.2024.2428992DOI Listing

Publication Analysis

Top Keywords

multinational corporations
12
corporations mncs
12
market share
12
mncs
9
pharmaceutical multinational
8
national firms
8
local companies
8
pharmaceutical
5
market
5
mncs exit
4

Similar Publications

Objectives: This study aimed to compared Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety, depression, and anger item bank among Korean, US and Dutch general population.

Methods: Between December 2021 and January 2022, we surveyed representative Korean participants (N = 2699). Then we compared the mean T-scores of PROMIS anxiety, depression, and anger full items bank among Korean, US (N = 1696) and the Dutch (N = 1002) populations.

View Article and Find Full Text PDF

Introduction: There are very few studies evaluating lipid-lowering treatments (LLTs) and low-density lipoprotein-cholesterol (LDL-C) goal attainment after the release of the 2019 guidelines of the European Societies of Cardiology (ESC) and Atherosclerosis (EAS). This manuscript shows baseline data of the Spanish subset from SANTORINI study (namely SANTORINI Spain) on LDL-C goal attainment and use of LLTs in patients at high and very high cardiovascular risk.

Methods: SANTORINI was a multinational, prospective, observational study involving patients at high and very high cardiovascular risk from 14 European countries in primary care and specialized healthcare settings.

View Article and Find Full Text PDF
Article Synopsis
  • The Pakistani pharmaceutical industry is experiencing significant changes, with national firms gaining a larger market share (74.51%) compared to multinational corporations (25.49%).
  • MNCs are facing challenges, including tough competition from local companies and ongoing mergers and acquisitions, which impact their ability to expand operations in the country.
  • The recent deregulation of prices for non-essential medicines by the federal government may encourage MNCs to invest in new technologies and infrastructure, essential for maintaining their market presence and improving operational efficiency.
View Article and Find Full Text PDF

Aims/hypothesis: The diagnosis of type 2 diabetes is increasing in young people worldwide. This study evaluated the frequency and clinical characteristics of young people presenting with type 2 diabetes from the multinational SWEET e.V Registry 2012-2021, including the first years of the COVID-19 pandemic.

View Article and Find Full Text PDF

Findings from clinical trials have led to advancement of care for patients with gynecologic malignancies. However, restrictive inclusion of patients into trials has been widely criticized for inadequate representation of the real-world population. Ideally, patients enrolled in clinical trials should represent a broader population to enhance external validity and facilitate translation of outcomes across all relevant groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!